NCT01600014 - Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp | Biotech Hunter

Enrollment

463

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Actinic Keratosis

Interventions

DRUG

Ingenol mebutate gel, 0.015%

Topical field treatment once daily for 3 consecutive days within a 25 cm2 treatment area on the face or scalp of AKs present or emerging after an initial treatment with ingenol mebutate gel, 0.015%

DRUG

Vehicle gel

Topical field treatment once daily for 3 consecutive days within a 25 cm2 treatment area on the face or scalp of AKs present or emerging after an initial treatment with ingenol mebutate gel, 0.015%

Trial Locations (13)

6008

St John of God Dermatology, Subiaco

44000

CHU de Nantes, Nantes

72076

Universitätsklinikum Tübingen, Tübingen

T5K 1X3

Stratica Medical, Edmonton

V5Z 4E8

Skin Care Centre, Vancouver

R3C 1R4

Dermadvances Research, Winnipeg

E1C 8X3

Durondel C.P. Inc./Dermatology Clinic, Moncton

L4M 6L2

UltraNova Skincare, Barrie

K9J 1Z2

SKiN Centre for Dermatology, Peterborough

N8W 5L7

Windsor Clinical Research Inc., Windsor

H2K 4L5

Innovaderm Research Inc., Montreal

G1V 4X7

Centre de Recherche Dermatologique, Québec

M13 9WL

Central Manchester University Hosptial, Manchester